Copyright Reports & Markets. All rights reserved.

Global Gastrointestinal Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Diagnostics
    • 1.4.3 Therapeutics
  • 1.5 Market by Application
    • 1.5.1 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
    • 1.5.2 Gastroenteritis
    • 1.5.3 GI Bleeding
    • 1.5.4 Irritable Bowel Syndrome
    • 1.5.5 Peptic Ulcer Disease (PUD)
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Gastrointestinal Therapeutics and Diagnostics Growth Trends by Regions
    • 2.2.1 Gastrointestinal Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Gastrointestinal Therapeutics and Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Gastrointestinal Therapeutics and Diagnostics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Gastrointestinal Therapeutics and Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Market Size
    • 3.1.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio
    • 3.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2019
  • 3.3 Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Area Served
  • 3.4 Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
  • 3.5 Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)
  • 5.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
  • 6.2 Gastrointestinal Therapeutics and Diagnostics Key Players in North America (2019-2020)
  • 6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 6.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
  • 7.2 Gastrointestinal Therapeutics and Diagnostics Key Players in Europe (2019-2020)
  • 7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 7.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

8 China

  • 8.1 China Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
  • 8.2 Gastrointestinal Therapeutics and Diagnostics Key Players in China (2019-2020)
  • 8.3 China Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 8.4 China Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
  • 9.2 Gastrointestinal Therapeutics and Diagnostics Key Players in Japan (2019-2020)
  • 9.3 Japan Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 9.4 Japan Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
  • 10.2 Gastrointestinal Therapeutics and Diagnostics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

11 India

  • 11.1 India Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
  • 11.2 Gastrointestinal Therapeutics and Diagnostics Key Players in India (2019-2020)
  • 11.3 India Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 11.4 India Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size (2015-2020)
  • 12.2 Gastrointestinal Therapeutics and Diagnostics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 12.4 Central & South America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Abbott Laboratories Company Details
    • 13.1.2 Abbott Laboratories Business Overview
    • 13.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Introduction
    • 13.1.4 Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020))
    • 13.1.5 Abbott Laboratories Recent Development
  • 13.2 AstraZeneca
    • 13.2.1 AstraZeneca Company Details
    • 13.2.2 AstraZeneca Business Overview
    • 13.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Introduction
    • 13.2.4 AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
    • 13.2.5 AstraZeneca Recent Development
  • 13.3 Eisai
    • 13.3.1 Eisai Company Details
    • 13.3.2 Eisai Business Overview
    • 13.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Introduction
    • 13.3.4 Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
    • 13.3.5 Eisai Recent Development
  • 13.4 Johnson & Johnson
    • 13.4.1 Johnson & Johnson Company Details
    • 13.4.2 Johnson & Johnson Business Overview
    • 13.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Introduction
    • 13.4.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
    • 13.4.5 Johnson & Johnson Recent Development
  • 13.5 Salix Pharmaceuticals
    • 13.5.1 Salix Pharmaceuticals Company Details
    • 13.5.2 Salix Pharmaceuticals Business Overview
    • 13.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Introduction
    • 13.5.4 Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
    • 13.5.5 Salix Pharmaceuticals Recent Development
  • 13.6 Takeda Pharmaceutical Company
    • 13.6.1 Takeda Pharmaceutical Company Company Details
    • 13.6.2 Takeda Pharmaceutical Company Business Overview
    • 13.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Introduction
    • 13.6.4 Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2015-2020)
    • 13.6.5 Takeda Pharmaceutical Company Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Gastrointestinal Therapeutics and Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Abbott Laboratories
    AstraZeneca
    Eisai
    Johnson & Johnson
    Salix Pharmaceuticals
    Takeda Pharmaceutical Company
    ...

    Market segment by Type, the product can be split into
    Diagnostics
    Therapeutics
    Market segment by Application, split into
    Gastroenteritis
    GI Bleeding
    Irritable Bowel Syndrome
    Peptic Ulcer Disease (PUD)
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now